Risk of neutropenia in inflammatory bowel disease patients treated with TNF inhibitors: A single-center, retrospective cohort study

Risk of neutropenia in inflammatory bowel disease patients treated with TNF inhibitors: A single-center, retrospective cohort study

Background/Aim: Tumor necrosis factor inhibitors (TNFi) have become the mainstay of treatment in moderate-to-severe cases of inflammatory bowel disease (IBD). Neutropenia has been reported in patients receiving TNFi for IBD and other diseases. In this study, we aimed to ascertain the relationship be...

Full description

Bibliographic Details
Main Authors: Dimah AlAskar, Mais AlSardi, Eman Al Sulais, Mahmoud Mosli, Turki AlAmeel
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:The Saudi Journal of Gastroenterology
Subjects:
inflammatory bowel disease
neutropenia
tnf inhibitors
Online Access:http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2020;volume=26;issue=4;spage=210;epage=215;aulast=AlAskar

Internet

http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2020;volume=26;issue=4;spage=210;epage=215;aulast=AlAskar

Similar Items